Cell Therapeutics Inc. (CTIC) Posts Q4 Loss of 9c/Share

March 7, 2012 6:55 AM
Cell Therapeutics Inc. (NASDAQ: CTIC) reported Q4 EPS of ($0.09), $0.01 worse than the analyst estimate of ($0.08).

For earnings history and earnings-related data on Cell Therapeutics Inc. (CTIC) click here.

Categories

Earnings